Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
<< previous   
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             1109 results found
no title author magazine year volume issue page(s) type
1001 The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder Harrigan, E.
 1996
 6 S3 p. 200-201
2 p.
 article
1002 The efficacy and safety of two fixed doses of ziprasidone in schizophrenia Reeves, K.
 1996
 6 S3 p. 201-
1 p.
 article
1003 The efficacy of sertraline in the treatment of major depression Bugarski-Kirola, D.
 1996
 6 S3 p. 124-
1 p.
 article
1004 The efficacy of zuclopenthixol acetate in the treatment of psychtic patients Dilbaz, N.
 1996
 6 S3 p. 60-
1 p.
 article
1005 The epidemiology of psychiatric disorders in HIV infection: Depression, mania and dementia Lyketsos, C.G.
 1996
 6 S3 p. 31-
1 p.
 article
1006 The functional neuroanatomy of prefrontal cortex: Implications for psychosurgery Geffen, L.B.
 1996
 6 S3 p. 230-
1 p.
 article
1007 The 5-HT1A receptor antagonist WAY-100635 enhances the behavioural effects of SSRIs Dourish, C.T.
 1996
 6 S3 p. 16-17
2 p.
 article
1008 The incidence of neutropenia and agranulocytosis in patients treated with clozapine in the UK and Ireland Atkin, K.
 1996
 6 S3 p. 172-
1 p.
 article
1009 The influence of ect on olfactory memory Sirota, Pinkhas
 1996
 6 S3 p. 182-
1 p.
 article
1010 The influence of fluoxetine on memory, anxiolytic activity and locomotor function in rats Nowakowska, E.
 1996
 6 S3 p. 190-
1 p.
 article
1011 The influence of morning and evening dosing on the pharmacokinetics of flesinoxan Van Harten, J.
 1996
 6 S3 p. 40-
1 p.
 article
1012 The influence of selected quinolones on central action of ethyl alcohol in laboratory animals Strzelec, J.
 1996
 6 S3 p. 2-
1 p.
 article
1013 The influence of testenate on the brain functional condition of aging Koldunov, V.
 1996
 6 S3 p. 188-
1 p.
 article
1014 The influense of ketamine pharmacokinetics on the activity of neurotransmitter systems in humans under surgical stress Davydova, N.A.
 1996
 6 S3 p. 134-
1 p.
 article
1015 The inositol depletion hypothesis: Promise and problems Belmaker, R.H.
 1996
 6 S3 p. 95-96
2 p.
 article
1016 The integration of intrinsic properties and synaptic inputs in locus coeruleus Williams, J.T.
 1996
 6 S3 p. 167-168
2 p.
 article
1017 The integrity of serotonin function and sensitization to cocaine Cunningham, K.A.
 1996
 6 S3 p. 161-
1 p.
 article
1018 The level of glutamine synthetase in Alzheimer's disease brain Burbaeva, G.
 1996
 6 S3 p. 188-
1 p.
 article
1019 The lithium ion: A foundation for psychopharmacological specificity Soares, J.C.
 1996
 6 S3 p. 84-
1 p.
 article
1020 The long-term efficacy and safety of paroxetine in panic disorder Judge, R.
 1996
 6 S3 p. 207-
1 p.
 article
1021 The mechanism of amyloid β-Peptide (1–42) toxicity in PC12 cells Fagarasan, M.
 1996
 6 S3 p. 144-145
2 p.
 article
1022 The mechanisms and clinical relevance of HIV associated brain damage Everall, I.P.
 1996
 6 S3 p. 31-
1 p.
 article
1023 The M1 muscarinic agonist xanomeline improves both cognitive and behavioral deficits in Alzheimer's disease Bodick, N.
 1996
 6 S3 p. 144-
1 p.
 article
1024 The modified dexamethasone suppression test (mDST) in chronic PTSD Hopwood, M.
 1996
 6 S3 p. 80-81
2 p.
 article
1025 The mRNA expression of G protein subclasses in the methamphetamine-induced behavioral sensitization Iwasa, Hiroto
 1996
 6 S3 p. 120-
1 p.
 article
1026 The need for faster and more effective antidepressants Deakin, J.F.W.
 1996
 6 S3 p. 16-
1 p.
 article
1027 The neurochemical and behavioural effects of the isomers of mirtazapine in normal rats McGrath, C.
 1996
 6 S3 p. 53-
1 p.
 article
1028 The neurochemical and endocrine actions of interleukin-1 Dunn, A.J.
 1996
 6 S3 p. 249-
1 p.
 article
1029 The neurodevelopmental hypothesis of schizophrenia: A critical clinical perspective Weinberger, D.R.
 1996
 6 S3 p. 169-
1 p.
 article
1030 The neuropathology of schizophrenia: Autoradiographic and in situ hybridization studies Kleinman, J.E.
 1996
 6 S3 p. 92-93
2 p.
 article
1031 Theoretical considerations of dose/concentration/effect relationships: Direct and indirect pharmacokinetic/dynamic models DeVane, C.L.
 1996
 6 S3 p. 81-82
2 p.
 article
1032 The ‘organic’ basis of Late-Onset Schizophrenia Sachdev, P.
 1996
 6 S3 p. 62-
1 p.
 article
1033 The paroxetine challenge test for in vivo evaluation of serotonin function in man Reist, C.
 1996
 6 S3 p. 176-
1 p.
 article
1034 The patient under neuroleptic treatment Lachaux, B.
 1996
 6 S3 p. 222-
1 p.
 article
1035 The peculiarities of the meperedine action in early ontogenesis Zlenko, H.
 1996
 6 S3 p. 109-
1 p.
 article
1036 The pharmacoeconomics of depression: Evaluating speed of onset as a key variable Langley, P.
 1996
 6 S3 p. 220-
1 p.
 article
1037 The pharmacological management of benzodiazepine withdrawal Schweizer, E.
 1996
 6 S3 p. 160-
1 p.
 article
1038 The prevention of mortality in bipolar disorder Coppen, A.
 1996
 6 S3 p. 219-
1 p.
 article
1039 The psychobiology of female specific mood disorders — Discussion Steiner, M.
 1996
 6 S3 p. 88-
1 p.
 article
1040 The quantitative analysis of a haloperidol derivative and its neurotoxic metabolites in baboons Avent, K.
 1996
 6 S3 p. 37-
1 p.
 article
1041 Therapeutic advantage of combined amitriptyline/Lithium and fluvoxamine/lithium treatments Miljković, B.
 1996
 6 S3 p. 130-
1 p.
 article
1042 Therapeutic effect of yohimbine in organic and non-organic erectile dysfunction Mann, K.
 1996
 6 S3 p. 14-
1 p.
 article
1043 Therapeutic strategies directed at the non-cholinergic transmitter systems Robert, P.H.
 1996
 6 S3 p. 30-
1 p.
 article
1044 The relationship between clozapine dose and plasma level and side effects Kalali, AH
 1996
 6 S3 p. 250-
1 p.
 article
1045 The relationship between negative symptoms and depression in schizophrenia Addington, D.
 1996
 6 S3 p. 62-63
2 p.
 article
1046 The relationship between serotonin and melatonin in the rat pineal gland Nathan, P.J.
 1996
 6 S3 p. 102-
1 p.
 article
1047 The rima moclobemide: More than an effective antidepressant? Amrein, R.
 1996
 6 S3 p. 164-
1 p.
 article
1048 The role of dopamine system in the striatum on the light pulse induced PRCS Fukuyama, H.
 1996
 6 S3 p. 103-
1 p.
 article
1049 The role of environmental and cognitive function in the development of behavioral sensitization Ohmori, T.
 1996
 6 S3 p. 160-
1 p.
 article
1050 The role of in vivo amygdala dopamine to cocaine self-administration behavior Hurd, Y.L.
 1996
 6 S3 p. 67-
1 p.
 article
1051 The role of NMDA systems in the developmental neurobehavioral toxicity of phencyclidine Scalzo, F.M.
 1996
 6 S3 p. 28-29
2 p.
 article
1052 The role of the serotonergic system on nocturnal cortisol and prolactin secretion in healthy humans Nathan, P.J.
 1996
 6 S3 p. 177-
1 p.
 article
1053 The role of the seta adrenergic system in CCK-4 induced panic symptoms Le Mellédo, J.-M.
 1996
 6 S3 p. 114-
1 p.
 article
1054 The role of the suprachiasmatic nuclei (SCN) as a biological clock: Effects of melatoninergic substances Turek, F.W.
 1996
 6 S3 p. 34-
1 p.
 article
1055 The serotonin transporter: From molecular pharmacology to therapeutics Langer, S.Z.
 1996
 6 S3 p. 86-
1 p.
 article
1056 The SSRI withdrawal syndrome Preskorn, S.
 1996
 6 S3 p. 121-
1 p.
 article
1057 The study of differentially expressed molecules in Alzheimer's disease brain Yamada, M.
 1996
 6 S3 p. 188-
1 p.
 article
1058 The study of signal transduction during the action of some memory modulators Kulikova, O.G.
 1996
 6 S3 p. 147-
1 p.
 article
1059 The treatment of adolescent depression: Where is the evidence? Martin, G.
 1996
 6 S3 p. 11-
1 p.
 article
1060 The use of electroconvulsive therapy in young people Walter, G.
 1996
 6 S3 p. 11-
1 p.
 article
1061 Thiazide derivatives block rapid AMPA receptordesensitization Rothman, Steven M.
 1996
 6 S3 p. 152-
1 p.
 article
1062 Thyroid hormone use in euthyroid patients in medicine, psychiatry, and surgery: A review Prange Jr., A.J.
 1996
 6 S3 p. 208-
1 p.
 article
1063 Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg ‘seroquel’ TID Gefvert, O.
 1996
 6 S3 p. 74-
1 p.
 article
1064 Timed melatonin administration on circadian rhythms and vigilance states Wirz-Justice, A.
 1996
 6 S3 p. 79-
1 p.
 article
1065 Tolcapone therapy improves cognitive functions in nondemented patients with advanced parkinson's disease Meco, G.
 1996
 6 S3 p. 131-
1 p.
 article
1066 Tolerability of low dose neuroleptics: A pseudoprospective, blind investigation of flupenthixol Fritze, J.
 1996
 6 S3 p. 148-
1 p.
 article
1067 Toxic haloperidol metabolites in human brain Eyles, D.
 1996
 6 S3 p. 4-
1 p.
 article
1068 Transient global amnesia-possible aetiopathogenetic mechanisms Bugarski-Kirola, D.
 1996
 6 S3 p. 187-
1 p.
 article
1069 Treatment and consequences of relapse in schizophrenia Lieberman, J.A.
 1996
 6 S3 p. 25-
1 p.
 article
1070 Treatment of alcohol withdrawal delirium and changes in monoamine Uchimura, N.
 1996
 6 S3 p. 44-
1 p.
 article
1071 Treatment of anxiety disorders in rheumatic heart disease Khokhlov, A.
 1996
 6 S3 p. 15-
1 p.
 article
1072 Treatment of neuropsychiatric disorders associated with HIV and AIDS Treisman, G.J.
 1996
 6 S3 p. 31-
1 p.
 article
1073 Treatment of schizophrenia and schizoaffetive disorder with a combination of clozapine and lithium Bender, S.A.
 1996
 6 S3 p. 200-
1 p.
 article
1074 Treatment of severe major depression: A double-blind study of sertraline and clomipramine Lépine, J.
 1996
 6 S3 p. 123-124
2 p.
 article
1075 Treatment of social phobia Montgomery, S.A.
 1996
 6 S3 p. 149-
1 p.
 article
1076 Treatment of the neuroleptic malignant syndrome by electroconvulsive therapy Seifertová, Dagmar
 1996
 6 S3 p. 172-
1 p.
 article
1077 Treatment refractoriness: New strategies Post, RM
 1996
 6 S3 p. 251-
1 p.
 article
1078 Treatment refractory depression: Long term issues Keller, M.B.
 1996
 6 S3 p. 93-
1 p.
 article
1079 Treatment-resistant depression: Resistant and complicated depression Price, L.H.
 1996
 6 S3 p. 93-
1 p.
 article
1080 Treatment with “Deproteinized calves' blood extract” in mild and moderate Alzheimer's Nivataphand, R.
 1996
 6 S3 p. 187-
1 p.
 article
1081 Treatment with mirtazapine is not related to complaints of sexual dysfunction Rekers, H.
 1996
 6 S3 p. 47-
1 p.
 article
1082 Tricycles and SSRIS enhance adenylate cyclase and cAMP-related behaviors in rat Maeda, H.
 1996
 6 S3 p. 55-
1 p.
 article
1083 Tryptophan depletion in recovered depressives and recovered bulimics Smith, K.A.
 1996
 6 S3 p. 129-130
2 p.
 article
1084 Twenty-four-hour urinary monoamine excretion in posttrumatic stress disorder Chung, Moonyong
 1996
 6 S3 p. 76-77
2 p.
 article
1085 Twenty years of clinical experience with the use of clozapine in severe psychotic patients Ciprian-Ollivier, J.
 1996
 6 S3 p. 200-
1 p.
 article
1086 Two open-label, long-term safety studies of sertindole Daniel, D.
 1996
 6 S3 p. 61-62
2 p.
 article
1087 Two-year follow-up after treatment of panic disorder with agoraphobia van Balkom, A.J.L.M.
 1996
 6 S3 p. 112-
1 p.
 article
1088 Type of onset and personality in panic disorder Hranov, L.
 1996
 6 S3 p. 205-
1 p.
 article
1089 Typical antipsychotics: The threshold doses strategy Ortega-Soto, H.A.
 1996
 6 S3 p. 199-
1 p.
 article
1090 Typical vs. Atypical antipsychotics in late-life psychosis Jeste, D.V.
 1996
 6 S3 p. 27-
1 p.
 article
1091 Ultra-rapid opioid detoxification using narcotic antagonists Kleber, H.D.
 1996
 6 S3 p. 162-
1 p.
 article
1092 Use of anticholinergic eye drops in differentiating Alzheimer's disease and depression Schweitzer, I.
 1996
 6 S3 p. 143-
1 p.
 article
1093 Use of benzodiazepines in opiate addicted patients — Results of an inquiry in basle Ladewig, D.
 1996
 6 S3 p. 2-
1 p.
 article
1094 Use of citalopram, a serotonin selective reuptake inhibitor, in OCD Stein, D.
 1996
 6 S3 p. 70-
1 p.
 article
1095 Use of combined SSRIS and moclobemide in treatment-resistant depression Grounds, D.
 1996
 6 S3 p. 127-
1 p.
 article
1096 Use of combined SSRIs and moclobemide in treatment-resistant depression Grounds, D.
 1996
 6 S3 p. 249-
1 p.
 article
1097 Use of narcotic antagonist in treating opioid addiction Fischman, M.W.
 1996
 6 S3 p. 163-
1 p.
 article
1098 Uses of narcotic antagonists in the treatment of addiction Kleber, H.D.
 1996
 6 S3 p. 163-164
2 p.
 article
1099 Utility-based measures of health-related quality of life in depression Bennett, K.J.
 1996
 6 S3 p. 128-
1 p.
 article
1100 Validation of the french version of PRIME-MD a primary care evaluation of mental disorder Boyer, P.
 1996
 6 S3 p. 210-
1 p.
 article
1101 Validity of the concept of dysthymia Waintraub, L.
 1996
 6 S3 p. 222-
1 p.
 article
1102 Valproate in migraine prophylaxis Mathew, Ninan T.
 1996
 6 S3 p. 27-
1 p.
 article
1103 Variety of lithium benefits Grof, P
 1996
 6 S3 p. 249-
1 p.
 article
1104 Weight gain and long term clozapine efficiency Jalenques, I.
 1996
 6 S3 p. 170-
1 p.
 article
1105 What if i do? What if i don't? Risk-benefit and ethical issues of neurosurgical treatment for mental disorders Mindus, P.
 1996
 6 S3 p. 230-231
2 p.
 article
1106 Will novel antipsychotics be the next standard of care for patients with schizophrenia: A worldwide report on risperidone Grebb, Jack
 1996
 6 S3 p. 33-
1 p.
 article
1107 Withdrawal of lorazepam long-term administered using six different plans Lemoine, P.
 1996
 6 S3 p. 118-
1 p.
 article
1108 Youth suicide in Victoria: A retrospective study Burrows, G.D.
 1996
 6 S3 p. 89-
1 p.
 article
1109 Zotepine in acute exacerbation of schizophrenia: A comparison versus chlorpromazine and placebo Cooper, S.J.
 1996
 6 S3 p. 148-
1 p.
 article
                             1109 results found
 
<< previous   
 
 Koninklijke Bibliotheek - National Library of the Netherlands